BRISTOL-MYERS SQUIBB CO(NYSE:BMY) stock News

BMY Latest News, Press Relases and Analysis

All

Press Releases

12 days ago - By: Chartmill

BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Offers a High Dividend Yield and Strong Profitability

14 days ago - By: Chartmill

BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Presents a Strong Value Investment Case

12 hours ago - By: The Motley Fool - Mentions: PFE

2 High-Yield Dividend Stocks Too Cheap to Ignore

3 days ago - By: SystImmune, Inc.

SystImmune, Inc. and Bristol Myers Squibb Announce First Global Phase I Results of Iza-bren, an EGFR x HER3 Bispecific Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors at ESMO 2025

4 days ago - By: The Motley Fool - Mentions: VEEV CRM

This Drug Discovery Stock Is Leading the Charge In Bringing AI to Healthcare. But Is It a Buy?

5 days ago - By: Benzinga - Mentions: PRGO PFE

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields

7 days ago - By: Zacks Investment Research - Mentions: NVS GILD

Will the Orbital Acquisition Strengthen BMY's Cell Therapy Portfolio?

7 days ago - By: Bristol Myers Squibb

Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types

7 days ago - By: SystImmune, Inc.

SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration

9 days ago - By: Zacks Investment Research - Mentions: AZN MRK

Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?

10 days ago - By: Stocktwits

Bristol Myers Squibb To Acquire Orbital Therapeutics In $1.5B Deal

10 days ago - By: Bristol Myers Squibb

Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics

10 days ago - By: Bristol Myers Squibb

Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection

17 days ago - By: Benzinga

Price Over Earnings Overview: Bristol-Myers Squibb

17 days ago - By: Chartmill - Mentions: CF EMN APA OXY ...

What's going on in today's session: S&P500 movers

18 days ago - By: Zacks Investment Research - Mentions: NVO MRK

Can Novo Nordisk's Restructuring Program Drive its Return to Growth?

18 days ago - By: Bloomberg - Mentions: ALNY ABBV

Alnylam Pulls TV Ad After Trump Crackdown on Drug Industry Spots

18 days ago - By: Zacks Investment Research - Mentions: CYTK

Can CYTK Clinch a Potential FDA Nod for Its Cardiovascular Drug?

18 days ago - By: Chartmill - Mentions: DHR NKE MRK PFE ...

In today's session, there are S&P500 stocks with remarkable trading volume.

19 days ago - By: Bristol Myers Squibb

Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease

19 days ago - By: Zacks Investment Research

Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know

20 days ago - By: Investor's Business Daily - Mentions: LLY NVO

Trump's Plan To Lower U.S. Drug Prices Faces Big Test

20 days ago - By: Zacks Investment Research - Mentions: MRK KRYS

Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor?

21 days ago - By: Stocktwits - Mentions: AMGN MRK

Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Program

25 days ago - By: Stocktwits

Bristol Myers To Sell Plaque Psoriasis Drug For Over 80% Discount Starting In 2026

25 days ago - By: Bristol Myers Squibb

Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)

25 days ago - By: Bloomberg

BRISTOL-MYERS SQUIBB CO (BMY) Stock News